EW Q2 2018 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$49B

Q2 2018 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$944M+12.1% YoY

Gross Profit

$710M75.3% margin

Operating Income

$282M29.9% margin

Net Income

$283M30.0% margin

EPS (Diluted)

$0.44

QoQ Revenue Growth

+5.5%

Cash Flow

Operating Cash Flow

$140M

Free Cash Flow

$87M

Stock-Based Comp.

$19M

Balance Sheet

Total Assets

$5.7B

Total Liabilities

$2.5B

Stockholders' Equity

$3.2B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$944M	$842M	+12.1%
Gross Profit	$710M	$633M	+12.2%
Operating Income	$282M	$255M	+10.8%
Net Income	$283M	$186M	+51.9%

Revenue Segments

Transcatheter Heart Valves

$585M62%

Surgical Heart Valve Therapy

$190M20%

Critical Care

$169M18%

Geographic Segments

UNITED STATES

$512M54%

Europe

$228M24%

JAPAN

$103M11%

Rest of World

$101M11%